Compass Therapeutics, Inc. (CMPX) has 20 已知的内部人和机构持有人记录. 最大持有人为 ORBIMED ADVISORS LLC 持有 15,219,994 股. 其他重要持有人包括 OrbiMed Genesis GP LLC 和 Schuetz Thomas J..
过去12个月，内部人进行了 18 笔交易，涉及 CMPX 股票 — 13 笔买入 (价值为 $25.24M) 和 0 笔卖出 (价值为 RSU 奖励). 内部人买入超过卖出，可能表明对公司前景有信心.
CMPX 內部人持股
最大持股人
ORBIMED ADVISORS LLC
15,219,994 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Orbimed Advisors Llc |
Director |
15,219,994 |
2022-11-10 |
|
| 2 |
Orbimed Genesis Gp Llc |
Director |
14,690,178 |
2022-05-13 |
|
| 3 |
Schuetz Thomas J. |
Chief Executive Officer |
6,603,336 |
2026-02-10 |
|
| 4 |
Tompkins Mark N. |
10 Percent Owner |
4,750,000 |
2018-07-30 |
|
| 5 |
Bisker-leib Vered |
Chief Executive Officer |
3,124,426 |
2024-02-09 |
|
| 6 |
Sunderland Julie |
Director |
2,212,907 |
2020-06-23 |
|
| 7 |
Sirard Cynthia |
Chief Medical Officer |
1,000,000 |
2026-01-05 |
|
| 8 |
Prasad Arjun |
Chief Commercial Officer |
1,000,000 |
2026-01-05 |
|
| 9 |
Shin Barry |
CFO |
525,000 |
2026-01-05 |
|
| 10 |
Anderson Errik |
10 Percent Owner |
383,642 |
2020-06-29 |
|
| 11 |
Lerner Neil |
Chief Accounting Officer |
382,500 |
2026-01-05 |
|
| 12 |
Jacobs Ian Seth |
President, Sec, CEO, & CFO |
250,000 |
2018-07-30 |
|
| 13 |
Anderman Jonathan |
General Counsel |
171,000 |
2026-01-05 |
|
| 14 |
Boylan James P |
Director |
90,000 |
2026-01-05 |
|
| 15 |
Gray Mary Ann |
Director |
90,000 |
2026-01-05 |
|
| 16 |
Ferneau Philip |
Director |
90,000 |
2026-01-05 |
|
| 17 |
Lindahl Richard S |
Director |
90,000 |
2026-01-05 |
|
| 18 |
Gordon Carl L |
Director |
90,000 |
2026-01-05 |
|
| 19 |
Chiniara Ellen |
Director |
90,000 |
2026-01-05 |
|
| 20 |
Kalled Susan |
Chief Scientific Officer |
60,000 |
2022-02-23 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-02-08 |
Schuetz Thomas J. |
Chief Executive Officer |
RSU 预扣税 |
36,687 |
$6.52 |
$239.2K |
| 2026-01-09 |
Schuetz Thomas J. |
Chief Executive Officer |
RSU 预扣税 |
46,777 |
$5.35 |
$250.26K |
| 2026-01-02 |
Prasad Arjun |
Chief Commercial Officer |
限制性股票授予 (RSU) |
1,000,000 |
$5.17 |
$5.17M |
| 2026-01-02 |
Prasad Arjun |
Officer |
未知 |
- |
- |
- |
| 2026-01-02 |
Anderman Jonathan |
General Counsel |
限制性股票授予 (RSU) |
150,000 |
$5.17 |
$775.5K |
| 2026-01-02 |
Boylan James P |
Director |
限制性股票授予 (RSU) |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Ferneau Philip |
Director |
限制性股票授予 (RSU) |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Sirard Cynthia |
Chief Medical Officer |
限制性股票授予 (RSU) |
1,000,000 |
$5.17 |
$5.17M |
| 2026-01-02 |
Sirard Cynthia |
Officer |
未知 |
- |
- |
- |
| 2026-01-02 |
Shin Barry |
CFO |
限制性股票授予 (RSU) |
125,000 |
$5.17 |
$646.25K |
| 2026-01-02 |
Schuetz Thomas J. |
CEO |
限制性股票授予 (RSU) |
2,000,000 |
$5.17 |
$10.34M |
| 2026-01-02 |
Lerner Neil |
Chief Accounting Officer |
限制性股票授予 (RSU) |
62,500 |
$5.17 |
$323.13K |
| 2026-01-02 |
Chiniara Ellen |
Director |
限制性股票授予 (RSU) |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Gordon Carl L |
Director |
限制性股票授予 (RSU) |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Gray Mary Ann |
Director |
限制性股票授予 (RSU) |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Lindahl Richard S |
Director |
限制性股票授予 (RSU) |
90,000 |
$5.17 |
$465.3K |
| 2025-11-16 |
Schuetz Thomas J. |
Chief Executive Officer |
RSU 预扣税 |
44,025 |
$4.83 |
$212.64K |
| 2025-05-27 |
Schuetz Thomas J. |
Chief Executive Officer |
知情买入 |
10,000 |
$2.11 |
$21.1K |
